Jackson Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,010
Closed -$314K 136
2020
Q4
$314K Hold
3,010
0.04% 124
2020
Q3
$213K Buy
+3,010
New +$210K 0.03% 119

Other funds holding MRNA

Jackson Wealth Management's MRNA Position: Q1 2021 in Review

Jackson Wealth Management sold out of Moderna (MRNA) in Q1 2021, closing a stake of 3,010 shares — an estimated $314K sold.

Jackson Wealth Management first reported a position in MRNA in Q3 2020 and held it in 2 quarters. The position peaked at $314K in Q4 2020. 776 funds tracked by Wall St. Rank hold MRNA as of Q1 2021.

  • Jackson Wealth Management reported no remaining Moderna position as of Q1 2021 after selling out during the quarter.
  • Jackson Wealth Management sold 3,010 Moderna shares in Q1 2021, an estimated $314K.
  • Jackson Wealth Management first reported a position in Moderna in Q3 2020 and held it in 2 quarters.
  • Jackson Wealth Management's Moderna position peaked at $314K in Q4 2020.
  • 776 funds tracked by Wall St. Rank held Moderna as of Q1 2021.

Based on Jackson Wealth Management's 13F filing for Q1 2021, filed 12 Apr 2021.